Cancer treatment with dendritic cell-based cancer vaccine Worldwide
What is included?
- clinical history-taking
- medical records review
- physical examination
- consultation with an oncologist
- consultation with an immunologist
- complete blood count (CBC)
- biochemical analysis of blood (kidney and liver function tests, electrolytes)
- inflammation blood tests
- ultrasound imaging
- CT/MRI scan
- fine needle aspiration biopsy of the tumor
- histopathological specimen examination
- immunohistochemistry test (IHC)
- pre-procedure patient preparation
- autologous dendritic cell harvesting
- dendritic cells incubation and activation
- infusion of mature dendritic cells
- post-procedure care
- symptomatic treatment
- cost of the drug production
- cost of essential medicines
- cost of essential materials
- nursing service
- discharge medical records
- further recommendations
What is Dendritic cancer vaccine?
Dendritic cell-based cancer vaccines are a type of immunotherapy in which the patient's dendritic cells are used to make the immune system attack cancer cells. Dendritic cells are significant to the immune response because they show foreign substances to T cells, white blood cells crucial to the immune reaction. In making a vaccine, dendritic cells from the patient's blood or bone marrow are taken and put in a lab where they are exposed to cancer antigens. The dendritic cells are then given back to the patient, where they can help the immune system fight cancer cells.
Each patient's dendritic cells are used to make a dendritic cell-based cancer vaccine, so each vaccine is unique. Dendritic cell-based cancer vaccines may target and kill cancer cells. They use dendritic cells to make the immune system attack cancer cells. Since vaccines are made from the patient's cells, they may have fewer side effects than other cancer treatments. Cancer vaccines made from dendritic cells might cause the immune system to respond to cancer cells in a way that lasts for a long time. It could make it less likely that cancer will come back.
Dendritic cell-based cancer vaccines are still experimental and studied in clinical trials.
Clinics for Dendritic cancer vaccine Worldwide
Doctors for Dendritic cancer vaccine Worldwide
FAQ
Where can I find Dendritic cancer vaccine?
Cancer treatment with dendritic cell-based cancer vaccine is available in Germany, Spain, Israel, and 1 other countries. Find out more about treatment destinations with AiroMedical.
What is the cost of Dendritic cancer vaccine?
The average price is €31,814.75. The cheapest option starts from €25,891.00 and the maximum cost can reach €37,626.00. Check AiroMedical to find the most suitable medical deal for your budget.